Skip to main content

Advertisement

Log in

Efficacy and Safety of Intralesional Triamcinolone Versus Combination of Triamcinolone with 5-Fluorouracil in the Treatment of Keloids and Hypertrophic Scars: A Systematic Review and Meta-analysis

  • Review
  • Special Topics
  • Published:
Aesthetic Plastic Surgery Aims and scope Submit manuscript

Abstract

Background

Although keloids and hypertrophic scars are common benign hyperproliferative growths of dermal fibroblasts, the clinical problems including physical and psychological problems are significant and impairing, with few proven treatments. Intralesional triamcinolone acetonide (TAC) and combination of TAC with 5-fluorouracil (5-FU) are widely used to treat keloids and hypertrophic scars, but their efficacy and safety remain controversial.

Methods

We systematically searched MEDLINE, EMBASE, Cochrane Library, and CNKI for relevant trials.

Results

The mean scar height and the erythema score in the TAC + 5-FU group were lower than those in the TAC group after treatment (P < 0.05). The effectiveness based on observer assessment after treatment in the TAC + 5-FU group was superior than that in the TAC group (P < 0.05); further, the subgroup analysis showed the TAC + 5-FU group was also superior than the TAC group in the treatment of hypertrophic scars (P = 0.01), and there were no significant differences in the treatment of keloid (P = 0.12). The effectiveness based on patient self-assessment after treatment in the TAC + 5-FU group was also superior than the TAC group (P < 0.05). The overall complication rate in the TAC + 5-FU group was lower than the TAC group (P < 0.05).

Conclusions

Combination of TAC with 5-FU is more effective and safer than TAC alone therapy in the treatment of keloids and hypertrophic scars. Data on keloids alone or hypertrophic scars alone are, however, limited. A better understanding of effective after intralesional combination of TAC with 5-FU in the treatment of keloids alone or hypertrophic scars alone is imperative.

Level of Evidence IV

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Singer AJ, Clark RA (1999) Cutaneous wound healing. N Engl J Med 34:738–746

    Google Scholar 

  2. Kelly AP (2004) Medical and surgical therapies for keloids. Dermatol Ther 17:212–218

    PubMed  Google Scholar 

  3. Gauglitz GG, Korting HC, Pavicic T, Ruzicka T, Jeschke MG (2011) Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med 17:113–125

    CAS  PubMed  Google Scholar 

  4. Polo M, Smith PD, Kim YJ, Wang X, Ko F, Robson MC (1999) Effect of TGF-beta2 on proliferative scar fibroblast cell kinetics. Ann Plast Surg 43:185–190

    CAS  PubMed  Google Scholar 

  5. Lee TY, Chin GS, Kim WJ, Chau D, Gittes GK, Longaker MT (1999) Expression of transforming growth factor beta 1, 2, and 3 proteins in keloids. Ann Plast Surg 43:179–184

    CAS  PubMed  Google Scholar 

  6. Muneuchi G, Suzuki S, Onodera M, Ito O, Hata Y, Igawa HH (2006) Long-term outcome of intralesional injection of triamcinolone acetonide for the treatment of keloid scars in Asian patients. Scand J Plast Reconstr Surg Hand Surg 40:111–116

    PubMed  Google Scholar 

  7. Davison SP, Dayan JH, Clemens MW, Sonni S, Wang A, Crane A (2009) Efficacy of intralesional 5-fluorouracil and triamcinolone in the treatment of keloids. Aesthet Surg J 29:40–46

    PubMed  Google Scholar 

  8. Jung JY, Roh MR, Kwon YS, Chung KY (2009) Surgery and perioperative intralesional corticosteroid injection for treating earlobe keloids: a korean experience. Ann Dermatol 21:221–225

    PubMed  PubMed Central  Google Scholar 

  9. Manuskiatti W, Fitzpatrick RE, Goldman MP (2001) Energy density and numbers of treatment affect response of keloidal and hypertrophic sternotomy scars to the 585-nm flashlamp-pumped pulsed-dye laser. J Am Acad Dermatol 45:557–565

    CAS  PubMed  Google Scholar 

  10. Roques C, Téot L (2008) The use of corticosteroids to treat keloids: a review. Int J Low Extrem Wounds 7:137–145

    PubMed  Google Scholar 

  11. Rockwell WB, Cohen IK, Ehrlich HP (1989) Keloids and hypertrophic scars: a comprehensive review. Plast Reconstr Surg 84:827–837

    CAS  PubMed  Google Scholar 

  12. Lee SS, Yosipovitch G, Chan YH, Goh CL (2004) Pruritus, pain, and small nerve fiber function in keloids: a controlled study. J Am Acad Dermatol 51:1002–1006

    PubMed  Google Scholar 

  13. Campaner AB, Ferreira LM, Gragnani A, Bruder JM, Cusick JL, Morgan JR (2006) Upregulation of TGF-beta1 expression may be necessary but is not sufficient for excessive scarring. J Invest Dermatol 126:1168–1176

    CAS  PubMed  Google Scholar 

  14. Mustoe TA, Cooter RD, Gold MH, Hobbs FD, Ramelet AA, Shakespeare PG, Stella M, Téot L, Wood FM, Ziegler UE, International Advisory Panel on Scar Management (2002) International clinical recommendations on scar management. Plast Reconstr Surg 110(560):571

    Google Scholar 

  15. Shah VV, Aldahan AS, Mlacker S, Alsaidan M, Samarkandy S, Nouri K (2016) 5-Fluorouracil in the treatment of keloids and hypertrophic scars: a comprehensive review of the literature. Dermatol Ther (Heidelb) 6:169–183

    Google Scholar 

  16. Wang XQ, Liu YK, Qing C, Lu SL (2009) A review of the effectiveness of antimitotic drug injections for hypertrophic scars and keloids. Ann Plast Surg 63:688–692

    CAS  PubMed  Google Scholar 

  17. Caviggioli F, Maione L, Vinci V, Klinger M (2010) The most current algorithms for the treatment and prevention of hypertrophic scars and keloids. Plast Reconstr Surg 126:1130–1132

    PubMed  Google Scholar 

  18. Fitzpatrick RE (1999) Treatment of inflamed hypertrophic scars using intralesional 5-FU. Dermatol Surg 25:224–232

    CAS  PubMed  Google Scholar 

  19. Atiyeh BS, Costagliola M, Hayek SN (2005) Keloid or hypertrophic scar: the controversy: review of the literature. Ann Plast Surg 54:676–680

    CAS  PubMed  Google Scholar 

  20. Chan HH, Wong DS, Ho WS, Lam LK, Wei W (2004) The use of pulsed dye laser for the prevention and treatment of hypertrophic scars in chinese persons. Dermatol Surg 30:987–994

    PubMed  Google Scholar 

  21. Ehrlich HP, Desmoulière A, Diegelmann RF, Cohen IK, Compton CC, Garner WL, Kapanci Y, Gabbiani G (1994) Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol 145:105–113

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Chodon T, Sugihara T, Igawa HH, Funayama E, Furukawa H (2000) Keloid-derived fibroblasts are refractory to Fas-mediated apoptosis and neutralization of autocrine transforming growth factor-beta1 can abrogate this resistance. Am J Pathol 157:1661–1669

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Ren Y, Zhou X, Wei Z, Lin W, Fan B, Feng S (2017) Efficacy and safety of triamcinolone acetonide alone and in combination with 5-fluorouracil for treating hypertrophic scars and keloids: a systematic review and meta-analysis. Int Wound J 14:480–487

    PubMed  Google Scholar 

  24. Khan MA, Bashir MM, Khan FA (2014) Intralesional triamcinolone alone and in combination with 5-fluorouracil for the treatment of keloid and hypertrophic scars. J Pak Med Assoc 64:1003–1007

    PubMed  Google Scholar 

  25. Asilian A, Darougheh A, Shariati F (2006) New combination of triamcinolone, 5-fluorouracil, and pulsed-dye laser for treatment of keloid and hypertrophic scars. Dermatol Surg 32:907–915

    CAS  PubMed  Google Scholar 

  26. Darougheh A, Asilian A, Shariati F (2009) Intralesional triamcinolone alone or in combination with 5-fluorouracil for the treatment of keloid and hypertrophic scars. Clin Exp Dermatol 34:219–223

    CAS  PubMed  Google Scholar 

  27. Srivastava S, Patil AN, Prakash C, Kumari H (2017) Comparison of intralesional triamcinolone acetonide, 5-fluorouracil, and their combination for the treatment of keloids. Adv Wound Care (New Rochelle) 6:393–400

    Google Scholar 

  28. Khalid FA, Mehrose MY, Saleem M, Yousaf MA, Mujahid AM, Rehman SU, Ahmad S, Tarar MN (2019) Comparison of efficacy and safety of intralesional triamcinolone and combination of triamcinolone with 5-fluorouracil in the treatment of keloids and hypertrophic scars: Randomised control trial. Burns 45:69–75

    PubMed  Google Scholar 

  29. Manuskiatti W, Fitzpatrick RE (2002) Treatment response of keloidal and hypertrophic sternotomy scars: comparison among intralesional corticosteroid, 5-fluorouracil, and 585-nm flashlamp-pumped pulsed-dye laser treatments. Arch Dermatol 138:1149–1155

    CAS  PubMed  Google Scholar 

  30. Goldman MP, Fitzpatrick RE (1995) Laser treatment of scars. Dermatol Surg 21:685–687

    CAS  PubMed  Google Scholar 

  31. Skuta GL, Parrish RK 2nd (1987) Wound healing in glaucoma filtering surgery. Surv Ophthalmol 32:149–170

    CAS  PubMed  Google Scholar 

  32. Nanda S, Reddy BS (2004) Intralesional 5-fluorouracil as a treatment modality of keloids. Dermatol Surg 30:54–57

    PubMed  Google Scholar 

  33. Friedman SJ, Butler DF, Pittelkow MR (1988) Perilesional linear atrophy and hypopigmentation after intralesional corticosteroid therapy. Report of two cases and review of the literature. J Am Acad Dermatol 19:537–541

    CAS  PubMed  Google Scholar 

  34. Ketchum LD, Smith J, Robinson DW, Masters FW (1966) The treatment of hypertrophic scar, keloid and scar contracture by triamcinolone acetonide. Plast Reconstr Surg 38:209–218

    CAS  PubMed  Google Scholar 

  35. Gupta S, Kalra A (2002) Efficacy and safety of intralesional 5-fluorouracil in the treatment of keloids. Dermatology 204:130–132

    CAS  PubMed  Google Scholar 

  36. Bijlard E, Steltenpool S, Niessen FB (2015) Intralesional 5-fluorouracil in keloid treatment: a systematic review. Acta Derm Venereol 95:778–782

    CAS  PubMed  Google Scholar 

  37. Apikian M, Goodman G (2004) Intralesional 5-fluorouracil in the treatment of keloid scars. Australas J Dermatol 45:140–143

    PubMed  Google Scholar 

  38. Ogawa R, Mitsuhashi K, Hyakusoku H, Miyashita T (2003) Postoperative electron-beam irradiation therapy for keloids and hypertrophic scars: retrospective study of 147 cases followed for more than 18 months. Plast Reconstr Surg 111:547–553

    PubMed  Google Scholar 

  39. Carvajal CC, Ibarra CM, Arbulo DL, Russo MN, Solé CP (2016) Postoperative radiotherapy in the management of keloids. Ecancermedicalscience 10:690

    PubMed  PubMed Central  Google Scholar 

  40. Lee SY, Park J (2015) Postoperative electron beam radiotherapy for keloids: treatment outcome and factors associated with occurrence and recurrence. Ann Dermatol 27:53–58

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Lebwohl M, Heymann W, Berth-Jones J (2017) Treatment of skin disease, 5th edn., comprehensive therapeutic strategies. Elsevier, Amsterdam

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Guang-Hua Guo.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Statement of Human and Animal Rights, or Ethical Approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed Consent

For this type of study, informed consent is not required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jiang, ZY., Liao, XC., Liu, MZ. et al. Efficacy and Safety of Intralesional Triamcinolone Versus Combination of Triamcinolone with 5-Fluorouracil in the Treatment of Keloids and Hypertrophic Scars: A Systematic Review and Meta-analysis. Aesth Plast Surg 44, 1859–1868 (2020). https://doi.org/10.1007/s00266-020-01721-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00266-020-01721-2

Keywords

Navigation